Search Form
First, enter a politician or zip code
Now, choose a category
 

Bernie Sanders' Public Statements on Issue: Drugs

Office: U.S. Senate (VT) - Jr, Independent
Date Title
May 17, 2017 Letter to the Honorable Roy Blunt and Patty Murray, Chairman and Ranking Member of Senate Appropriations Subcommittee on Labor, HHS, and Education, and the Honorable Thad Cochran and Patrick Leahy, Chairman and Vice-Chairman of Senate Appropriations Committee - Increase Funding to Combat Opioid Epidemic
May 4, 2017 Vermont Awarded $2 Million Federal Grant to Address Opioid Misuse
April 26, 2017 Letter to the Hon. Mitch McConnell, Senate Majority Leader, and the Hon. Paul Ryan, Speaker of the House - Funding for Opioid Crisis and Medical Research
March 29, 2017 As Health Care Debate Shifts, Senator Franken and Senate Colleagues Lead Milestone Effort to Bring Down Prescription Drug Prices
March 15, 2017 Letter to Dr. Stephen Ostroff, Acting Commissioner of US Food and Drug Administration - Information Request on FDA approval of new Deflazacort Drug
Feb. 28, 2017 Affordable and Safe Prescription Drug Importation Act Introduced to Help Lower Skyrocketing Cost of Medicine
Feb. 17, 2017 Letter to the Hon. Jean-Claude Junker, President of the European Commission - European Union Support to Combat the Fentanyl Crisis
Feb. 13, 2017 Letter to Jeffrey S. Aronin, Chairman and Chief Executive Officer of Marathon Pharmaceuticals, LLC - Information Request on Pricing Plan for Emflaza (Deflazacort)
Jan. 17, 2017 Letter to the Hon. Chuck Rosenberg - Regarding Query on Enforcement Efforts Against Wholesale Opioid Distributors
Dec. 16, 2016 Letter to Gary Ruckelshaus, Vice President and General Counsel of Heritage Pharmaceuticals Inc. - Information Request Regarding Alleged Price Fixing of Certain Drugs
Dec. 14, 2016 Letter to the Hon. Jamal El-Hindi, Acting Director of Financial Enforcement Network - Regarding Guidance on Banking Services
Dec. 13, 2016 Letter to Jamal El-Hindi, Acting Director of Financial Crimes Enforcement Network - Guidance on Banking Service for Vendors Working with Legal Marijuana Businesses
Dec. 1, 2016 Letter to the Hon. Paul Ryan, Speaker of the House, the Hon. Mitch McConnell, Senate Majority Leader; the Hon. Nancy Pelosi, House Minority Leader and the Hon. Harry Reid, Senate Minority Leader - Call for Passage of Foster Care Reforms
Nov. 3, 2016 Letter to the Honorable Loretta E. Lynch, Attorney General of the United States and the Hon. Edith Ramirez, Chairwoman of the Federal Trade Commission - Request to Investigate Cost of Diabetes Products
Oct. 28, 2016 Letter to the Hon. Loretta Lynch, U.S. Attorney General and the Hon. Chuck Rosenberg, Acting Administrator, DEA - Efforts Against Wholesale Opioid Distributors
Sept. 21, 2016 Legislative Branch Appropriations Act, 2017--Motion to Proceed--
Aug. 30, 2016 Letter to Ms. Heather Bresch, Chief Executive Officer of Mylan - Concerns About Mylan's EpiPen Price HIke
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
July 13, 2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill
July 13, 2016 Sanders Statement on Opioid Legislation
July 7, 2016 Letter to the Honorable Robert M. Califf, Commissioner of the Food and Drug Administration - Condemning AstraZeneca for Putting Profits Over People
June 1, 2016 Letter to The Honorable Sylvia M. Burwell, Secretary of Health and Human Services - Urging DHHS to Increase Access to Opioid Addiction Treatment
May 31, 2016 Sanders, Nurses, Doctors Call for Medicare-for-All, Senator Backs California Ballot Initiative on Prescription Drug Prices
May 25, 2016 Sanders Backs California Ballot Initiative to Rein in Drug Prices at Meeting with HIV/AIDS Advocates
March 28, 2016 Letter to the Honorable Sylvia M. Burwell, Secretary of Health and Human Services and Francis Collins, Director of National Institutes of Health - Act Now on Drug Affordability
March 13, 2016 Full Rush Transcript Senator Bernie Sanders //CNN TV One Democratic Presidential Town Hall
March 11, 2016 Sanders Announces $1.2 Million in Health Center Funds for Substance Abuse Treatment in Vermont
Jan. 26, 2016 Sanders Places Hold on FDA Nominee
Jan. 16, 2016 The Fourth Democratic Debate
Dec. 23, 2015 Following Sanders Investigation, Vermont Secures Discount on Life-Saving Drug
Dec. 19, 2015 Third Democratic Debate
Nov. 29, 2015 New Hampshire Democratic Party Jefferson-Jackson Dinner
Nov. 21, 2015 Sanders Calls Criminal Justice Reform the "Civil Rights Issue of the Century'
Nov. 14, 2015 Democratic Debate Transcript: Clinton, Sanders, O'Malley in Iowa
Nov. 7, 2015 Sanders Statement on Criminal Justice Reform and Marijuana Law
Oct. 29, 2015 Trade Act of 2015
Oct. 29, 2015 Letter to Sylvia M. Burwell, Secretary of the Department of Health and Human Services - Overdose Prevention
Oct. 28, 2015 Sanders: Let States Make Marijuana Legal
Oct. 13, 2015 CNN Democratic Party Presidential Debate
July 29, 2015 Letter to Stephanie Rawlings-Blake, President of the United States Conference of Mayors, and Sallie Clark, President of the National Association of Counties - Naloxone Cost and Access
July 13, 2015 Letter to John Kickenlooper, Governor of Colorado, Nancy Wyman, Lieutenant Governor of Connecticut, and Marty Jackley, Attorney General of South Dakota - Reduction in the Cost of Naloxone
March 2, 2015 Letter to Jack Zhang, CEO of Amphastar Pharmaceuticals, Incorporated - Price Increases for Drug that Police Use to Treat Overdoses
Jan. 1, 2015 Issue Position: Racial Justice
Dec. 23, 2014 Letter to Sylvia Mathews Burwell, Secretary of the Department of Health and Human Services - Opioid Abuse
Dec. 22, 2014 Letter to Sylvia Mathews Burwell, Secretary of U.S. Department of Health and Human Services - More Needs to be Done to Address Heroin Epidemic
Nov. 20, 2014 Drugmakers Mum on Huge Price Hikes
Nov. 20, 2014 US News - Price Spikes for Once-Cheap Generic Drugs Draw Scrutiny from Senate Lawmakers
Nov. 20, 2014 Sanders and Cummings Introduce Legislation to Require Drug Company Rebates for Generic Drugs
Nov. 11, 2014 Congressional Panel to Probe Generic Drug Price Hikes
Oct. 9, 2014 Sanders Investigating Drug Prices
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top